Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The novel proteasome inhibitor carfilzomib activates and enhances extrinsic apoptosis involving stabilization of death receptor 5

11 May 2015

Abstract excerpt

// Bo Han 1, 2 , Weilong Yao 1 , You-Take Oh 1 , Jing-Shan Tong 3 , Shaohua Li 1, 4 , Jiusheng Deng 1 , Ping Yue 1 , Fadlo R. Khuri 1 , Shi-Yong Sun 1 1 Department of Hematology and Oncology, Emory University School of Medicine and Winship Cancer Institute, Atlanta, GA, USA 2 State Key Laboratory of Oral Disease and Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autophagy in Disease and Therapy
Share to Cell death mechanisms and regulation
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26009898
DOI: 10.18632/oncotarget.3947

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The novel proteasome inhibitor carfilzomib activates and enhances extrinsic apoptosis involving stabilization of death receptor 5PMID 26009898Read ↗

The Farnesyltransferase Inhibitor Lonafarnib Induces CCAAT/Enhancer-binding Protein Homologous Protein-dependent Expression of Death Receptor 5, Leading to Induction of Apoptosis in Human Cancer CellsSemantic proximity Read ↗

Targeting apoptotic pathways for cancer therapySemantic proximity Read ↗

State of Art and Recent Developments of Anti-Cancer Strategies Based on TRAILSemantic proximity Read ↗

Therapeutics Targeting the Core Apoptotic MachinerySemantic proximity Read ↗

Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole.Semantic proximity Read ↗

Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling.Semantic proximity Read ↗

Apoptosis-inducing agents: a patent review (2010 – 2013)Semantic proximity Read ↗

Mcl‐1 targeting could be an intriguing perspective to cure cancerSemantic proximity Read ↗

Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatinSemantic proximity Read ↗

The role of the ubiquitin proteasome system in lymphomaSemantic proximity Read ↗

FADD as a key molecular player in cancer progressionSemantic proximity Read ↗

Targeting XIAP for Promoting Cancer Cell Death—The Story of ARTS and SMACSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.